Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes? An immunoinformatic analysis

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 2, 2014, Pages 290-300

  Homan, E Jane ^a   Bremel, Robert D ^a  

^a IoGenetics LLC   (United States)

Author keywords

Cathepsin; Epitope; Immunoinformatics; Jeryl Lynn; MHC; Mumps; Vaccine

Indexed keywords

B LYMPHOCYTE ANTIGEN; CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; HN PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN; EPITOPE; MUMPS VACCINE;

ANTIBODY TITER; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; IMMUNE RESPONSE; MUMPS; MUMPS VIRUS; MUTATION RATE; NONHUMAN; PREDICTION; PROTEIN CLEAVAGE; SEROLOGY; VIRUS STRAIN; WILD TYPE; COMMUNICABLE DISEASES, EMERGING; GENETICS; HUMAN; IMMUNOLOGY;

COMMUNICABLE DISEASES, EMERGING; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HN PROTEIN; HUMANS; MUMPS; MUMPS VACCINE;

EID: 84897006376     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.27139     Document Type: Article

References (58)

1. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 2008; 47:1458-67; PMID:18959494; http://dx.doi. org/10.1086/591196
2. Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L, Kyaw MH, Baughman AL, Menitove JE, Hickman CJ, Bellini WJ, et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis 2011; 204:1413-22; PMID:21933874; http://dx.doi. org/10.1093/infdis/jir526
3. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009; 27:6186- 95; PMID:19815120; http://dx.doi.org/10.1016/j. vaccine.2009.06.109
4. Kaaijk P, van der Zeijst B, Boog M, Hoitink C. Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype. Euro Surveill 2008; 13:18914; PMID:18761918
5. Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect 2012; (Forthcoming) 1-16; PMID:22687578
6. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13:12- 7; PMID:17370510; http://dx.doi.org/10.3201/ eid1301.060649 (Pubitemid 46057832)
7. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012; 367:1704-13; PMID:23113481; http://dx.doi.org/10.1056/NEJMoa1202865
8. Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, Lizama A, Diras D, Mathew A, Camacho EJ, et al. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control-Guam 2009 to 2010. Pediatr Infect Dis J 2013; 32:374-80; PMID:23099425; http://dx.doi.org/10.1097/INF. 0b013e318279f593
9. Centers for Disease Control and Prevention (CDC). Mumps outbreak on a university campus-California, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:986-9; PMID:23222373
10. World Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec 2007; 82:51-60; PMID:17304707
11. Afzal MA, Pickford AR, Forsey T, Heath AB, Minor PD. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J Gen Virol 1993; 74:917-20; PMID:8492099; http://dx.doi. org/10.1099/0022-1317-74-5-917 (Pubitemid 23154296)
12. World Health Organization. Mumps virus nomenclature update. Wkly Epidemiol Rec 2012; 87:217-24
13. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45:459-66; PMID:17638194; http://dx.doi.org/10. 1086/520028 (Pubitemid 47204462)
14. Plotkin SA. Commentary: Mumps vaccines: do we need a new one? Pediatr Infect Dis J 2013; 32:381- 2; PMID:23552675; http://dx.doi.org/10.1097/ INF.0b013e3182809dda
15. Jin L, Rima B, Brown D, Orvell C, Tecle T, Afzal M, Uchida K, Nakayama T, Song JW, Kang C, et al. Proposal for genetic characterisation of wildtype mumps strains: preliminary standardisation of the nomenclature. Arch Virol 2005; 150:1903- 9; PMID:15959834; http://dx.doi.org/10.1007/ s00705-005-0563-4 (Pubitemid 41176643)
16. Kulkarni-Kale U, Ojha J, Manjari GS, Deobagkar DD, Mallya AD, Dhere RM, Kapre SV. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 2007; 359:436-46; PMID:17081582; http://dx.doi. org/10.1016/j.virol.2006.09.040 (Pubitemid 46274873)
17. Kövamees J, Rydbeck R, Orvell C, Norrby E. Hemagglutinin- neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res 1990; 17:119-29; PMID:1705373; http://dx.doi. org/10.1016/0168-1702(90)90073-K (Pubitemid 20342025)
18. Orvell C. The reactions of monoclonal antibodies with structural proteins of mumps virus. J Immunol 1984; 132:2622-9; PMID:6201553 (Pubitemid 14136865)
19. Cusi MG, Fischer S, Sedlmeier R, Valassina M, Valensin PE, Donati M, Neubert WJ. Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. Virus Res 2001; 74:133-7; PMID:11226581; http://dx.doi. org/10.1016/S0168-1702(00)00254-9 (Pubitemid 32168200)
20. Rubin S, Mauldin J, Chumakov K, Vanderzanden J, Iskow R, Carbone K. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 2006; 24:2662-8; PMID:16309801; http://dx.doi.org/10.1016/j. vaccine.2005.10.050 (Pubitemid 43290398)
21. Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 2008; 198:508-15; PMID:18558869; http://dx.doi.org/10.1086/590115
22. Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 2012; 86:615-20; PMID:22072778; http://dx.doi.org/10.1128/JVI.06125-11
23. Šantak M, Lang-Balija M, Ivancic-Jelecki J, Košuti?- Gulija T, Ljubin-Sternak S, Forcic D. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies. Epidemiol Infect 2013; 141:1298-309; PMID:22954346; http://dx.doi. org/10.1017/S0950268812001896
24. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008; 197:950-6; PMID:18419470; http://dx.doi.org/10. 1086/528993 (Pubitemid 351590022)
25. LeBaron CW, Forghani B, Matter L, Reef SE, Beck C, Bi D, Cossen C, Sullivan BJ. Persistence of rubella antibodies after 2 doses of measles-mumpsrubella vaccine. J Infect Dis 2009; 200:888-99; PMID:19659440; http://dx.doi.org/10.1086/605410
26. Latner DR, McGrew M, Williams N, Lowe L, Werman R, Warnock E, Gallagher K, Doyle P, Smole S, Lett S, et al. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin Vaccine Immunol 2011; 18:35- 42; PMID:21047998; http://dx.doi.org/10.1128/ CVI.00284-10
27. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008; 197:1662-8; PMID:18419346; http://dx.doi.org/10.1086/588197 (Pubitemid 351919629)
28. Jokinen S, Osterlund P, Julkunen I, Davidkin I. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis 2007; 196:861-7; PMID:17703416; http://dx.doi.org/10.1086/521029 (Pubitemid 47378935)
29. Hanna-Wakim R, Yasukawa LL, Sung P, Arvin AM, Gans HA. Immune responses to mumps vaccine in adults who were vaccinated in childhood. J Infect Dis 2008; 197:1669-75; PMID:18419345; http://dx.doi. org/10.1086/588195 (Pubitemid 351919630)
30. Moss CX, Tree TI, Watts C. Reconstruction of a pathway of antigen processing and class II MHC peptide capture. EMBO J 2007; 26:2137- 47; PMID:17396153; http://dx.doi.org/10.1038/ sj.emboj.7601660 (Pubitemid 46625795)
31. Chapiro J, Claverol S, Piette F, Ma W, Stroobant V, Guillaume B, Gairin JE, Morel S, Burlet-Schiltz O, Monsarrat B, et al. Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation. J Immunol 2006; 176:1053-61; PMID:16393993 (Pubitemid 43099706)
32. Blanchard N, Shastri N. Coping with loss of perfection in the MHC class I peptide repertoire. Curr Opin Immunol 2008; 20:82-8; PMID:18243675; http://dx.doi.org/10.1016/j.coi.2007.12.004
33. Sijts EJ, Kloetzel PM. The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell Mol Life Sci 2011; 68:1491-502; PMID:21387144; http://dx.doi.org/10.1007/ s00018-011-0657-y
34. Bremel RD, Homan EJ. Recognition of higher order patterns in proteins: immunologic kernels. PLoS One 2013; 8:e70115; PMID:23922927; http://dx.doi. org/10.1371/journal.pone.0070115
35. Bremel RD, Homan EJ. An integrated approach to epitope analysis II: A system for proteomicscale prediction of immunological characteristics. Immunome Res 2010; 6:8; PMID:21044290; http://dx.doi.org/10.1186/1745-7580-6-8
36. Homan EJ, Bremel RD. Patterns of predicted T-cell epitopes associated with antigenic drift in influenza H3N2 hemagglutinin. PLoS One 2011; 6:e26711; PMID:22039539; http://dx.doi.org/10.1371/ journal.pone.0026711
37. Biniossek ML, Nägler DK, Becker-Pauly C, Schilling O. Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S. J Proteome Res 2011; 10:5363-73; PMID:21967108; http://dx.doi. org/10.1021/pr200621z
38. Yates PJ, Afzal MA, Minor PD. Antigenic and genetic variation of the HN protein of mumps virus strains. J Gen Virol 1996; 77:2491-7; PMID:8887482; http://dx.doi.org/10.1099/0022-1317-77-10-2491 (Pubitemid 26348371)
39. Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C, Korber B. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 2004; 14:1229-46; PMID:15175256; http://dx.doi. org/10.1093/glycob/cwh106 (Pubitemid 39585357)
40. Szabó TG, Palotai R, Antal P, Tokatly I, Tóthfalusi L, Lund O, Nagy G, Falus A, Buzás EI. Critical role of glycosylation in determining the length and structure of T cell epitopes. Immunome Res 2009; 5:4; PMID:19778434; http://dx.doi. org/10.1186/1745-7580-5-4
41. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005; 307:1630-4; PMID:15761154; http://dx.doi.org/10.1126/science. 1108003 (Pubitemid 40354746)
42. Beers C, Honey K, Fink S, Forbush K, Rudensky A. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages. J Exp Med 2003; 197:169-79; PMID:12538657; http://dx.doi. org/10.1084/jem.20020978 (Pubitemid 36152312)
43. Aiba Y, Kometani K, Hamadate M, Moriyama S, Sakaue-Sawano A, Tomura M, Luche H, Fehling HJ, Casellas R, Kanagawa O, et al. Preferential localization of IgG memory B cells adjacent to contracted germinal centers. Proc Natl Acad Sci U S A 2010; 107:12192-7; PMID:20547847; http://dx.doi. org/10.1073/pnas. 1005443107
44. Sette A, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, Johnston RJ, Peters B, Rafii-El- Idrissi Benhnia M, Hoffmann J, Su HP, et al. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 2008; 28:847-58; PMID:18549802; http://dx.doi.org/10.1016/j.immuni.2008.04.018 (Pubitemid 351778408)
45. Tanchot C, Rocha B. CD8 and B cell memory: same strategy, same signals. Nat Immunol 2003; 4:431- 2; PMID:12719734; http://dx.doi.org/10.1038/ ni0503-431 (Pubitemid 36592434)
46. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003; 421:852- 6; PMID:12594515; http://dx.doi.org/10.1038/ nature01441 (Pubitemid 36254145)
47. Amanna IJ, Slifka MK. Quantitation of rare memory B cell populations by two independent and complementary approaches. J Immunol Methods 2006; 317:175-85; PMID:17055526; http://dx.doi. org/10.1016/j.jim.2006.09.005 (Pubitemid 44809205)
48. Hebeis BJ, Klenovsek K, Rohwer P, Ritter U, Schneider A, Mach M, Winkler TH. Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med 2004; 199:593-602; PMID:14769849; http://dx.doi.org/10.1084/jem. 20030091 (Pubitemid 38233842)
49. McHeyzer-Williams M, Okitsu S, Wang N, McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev Immunol 2012; 12:24-34; PMID:22158414
50. Ivancic-Jelecki J, Santak M, Forcic D. Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains. Infect Genet Evol 2008; 8:603-13; PMID:18508415; http://dx.doi.org/10.1016/j.meegid.2008.04.007
51. Larsen JE, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res 2006; 2:2; PMID:16635264; http://dx.doi. org/10.1186/1745-7580-2-2
52. Wold S, Sjorstrom M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom Intell Lab Syst 2001; 58:109-30; http://dx.doi.org/10.1016/ S0169-7439(01)00155-1 (Pubitemid 33033283)
53. Greenbaum J, Sidney J, Chung J, Brander C, Peters B, Sette A. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 2011; 63:325-35; PMID:21305276; http://dx.doi. org/10.1007/s00251-011-0513-0
54. Breiman L. Bagging predictors. Mach Learn 1996; 24:123-40; http://dx.doi.org/10.1007/BF00058655 (Pubitemid 126724382)
55. Nielsen M, Lundegaard C, Blicher T, Peters B, Sette A, Justesen S, Buus S, Lund O. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol 2008; 4:e1000107; PMID:18604266; http://dx.doi.org/10.1371/journal.pcbi.1000107
56. Johnson NL. Systems of frequency curves generated by methods of translation. Biometrika 1949; 36:149- 76; PMID:18132090
57. Tholen S, Biniossek ML, Gessler AL, Müller S, Weisser J, Kizhakkedathu JN, Reinheckel T, Schilling O. Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts. Biol Chem 2011; 392:961- 71; PMID:21972973; http://dx.doi.org/10.1515/ BC.2011.162
58. Ward JH. Hierarchical Grouping to Optimize an Objective Function. J Am Stat Assoc 1963; 48:236- 44; http://dx.doi.org/10.1080/01621459.1963.10500 845